Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Regillo

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
American Journal of Ophthalmology|July 15, 2023
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly InjectionsAnam Akhlaq, David Williams, W Lloyd Clark, et al.
Retina (Philadelphia, Pa.)|July 24, 2024
VITREORETINAL OUTCOMES FOLLOWING SECONDARY INTRAOCULAR LENS IMPLANTATION WITH PARS PLANA VITRECTOMYGabriel T Kaufmann, Omesh Gupta, Julia Yu, et al.
BMJ Open Ophthalmology|February 16, 2023
Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)Rui Wang, Cynthia K McClard, Stephen Laswell, et al.
Lancet (London, England)|January 27, 2022
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trialsJeffrey S Heier, Arshad M Khanani, Carlos Quezada Ruiz, et al.
Current Eye Research|February 1, 2021
Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone AcetonideBrandon Kuley, Philip P Storey, Turner D Wibbelsman, et al.
The British Journal of Ophthalmology|May 16, 2020
Impact of contact versus non-contact wide-angle viewing systems on outcomes of primary retinal detachment repair (PRO study report number 5)Marisa G Tieger, Marianeli Rodriguez, Jay C Wang, et al.
Ophthalmology|July 26, 2016
Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical TrialLyndon da Cruz, Jessy D Dorn, Mark S Humayun, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degenerationWei Chen, Dwight Stambolian, Albert O Edwards, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
American Journal of Ophthalmology|July 15, 2023
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly InjectionsAnam Akhlaq, David Williams, W Lloyd Clark, et al.
Retina (Philadelphia, Pa.)|July 24, 2024
VITREORETINAL OUTCOMES FOLLOWING SECONDARY INTRAOCULAR LENS IMPLANTATION WITH PARS PLANA VITRECTOMYGabriel T Kaufmann, Omesh Gupta, Julia Yu, et al.
BMJ Open Ophthalmology|February 16, 2023
Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)Rui Wang, Cynthia K McClard, Stephen Laswell, et al.
Lancet (London, England)|January 27, 2022
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trialsJeffrey S Heier, Arshad M Khanani, Carlos Quezada Ruiz, et al.
Current Eye Research|February 1, 2021
Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone AcetonideBrandon Kuley, Philip P Storey, Turner D Wibbelsman, et al.
The British Journal of Ophthalmology|May 16, 2020
Impact of contact versus non-contact wide-angle viewing systems on outcomes of primary retinal detachment repair (PRO study report number 5)Marisa G Tieger, Marianeli Rodriguez, Jay C Wang, et al.
Ophthalmology|July 26, 2016
Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical TrialLyndon da Cruz, Jessy D Dorn, Mark S Humayun, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degenerationWei Chen, Dwight Stambolian, Albert O Edwards, et al.
Pageof 4